Covered recipient · General Payments record
ERIC BRYCE MANN
Allopathic & Osteopathic Physicians Ophthalmology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2021 · Entire year
$89,651.90
222 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2021 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,709.50 | 29 |
| Consulting Fee | $7,453.00 | 5 |
| Food and Beverage | $5,058.67 | 165 |
| Honoraria | $3,700.00 | 2 |
| Travel and Lodging | $2,730.73 | 21 |
By paying entity
PY2021 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Allergan, Inc. | $67,651.06 | 92 |
| Mallinckrodt Hospital Products Inc. | $6,265.87 | 17 |
| Aerie Pharmaceuticals, Inc. | $6,212.92 | 11 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $4,025.01 | 21 |
| Bausch & Lomb, a division of Bausch Health US, LLC | $2,325.52 | 11 |
| Kala Pharmaceuticals, Inc. | $1,407.69 | 14 |
| Sight Sciences, Inc. | $667.04 | 17 |
| Alcon Vision LLC | $279.68 | 12 |
| Ocular Therapeutix, Inc. | $242.80 | 6 |
| Dompe US, Inc. | $173.70 | 5 |
| Glaukos Corporation | $143.50 | 1 |
| TISSUETECH, INC. | $78.38 | 5 |
| Eyevance Pharmaceuticals LLC | $73.14 | 3 |
| Novartis Pharmaceuticals Corporation | $72.16 | 5 |
| Johnson & Johnson Surgical Vision, Inc. | $20.36 | 1 |
| EyePoint Pharmaceuticals US, Inc. | $13.07 | 1 |
Page 2 of 5; records 51–100 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ERIC BRYCE MANN
NPI 1508847930 · CMS profile ID 295246
Allopathic & Osteopathic Physicians / Ophthalmology
DOVER, NJ
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 5; records 51–100 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1508847930?year=2021&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ERIC BRYCE MANN, NPI 1508847930, CMS profile ID 295246. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508847930?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
- APA 7
- IndustryPayments. (2026). ERIC BRYCE MANN, NPI 1508847930, CMS profile ID 295246. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508847930?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
- Bluebook
- ERIC BRYCE MANN, NPI 1508847930, CMS profile ID 295246, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1508847930?year=2021&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2021
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30
222 matching records · $89,651.90 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 222.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $2,100.00 | 10/04/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164197 | CMS |
| Allergan, Inc. | $16.93 | 09/29/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863179 | CMS |
| Glaukos Corporation | $143.50 | 09/29/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 854557567 | CMS |
| Aerie Pharmaceuticals, Inc. | $14.36 | 09/27/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 779221621 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.50 | 09/27/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851880007 | CMS |
| Mallinckrodt Hospital Products Inc. | $15.00 | 09/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367825 | CMS |
| Allergan, Inc. | $12.50 | 09/23/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863175 | CMS |
| Allergan, Inc. | $2.25 | 09/23/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863177 | CMS |
| Alcon Vision LLC | $16.29 | 09/21/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 797771203 | CMS |
| Kala Pharmaceuticals, Inc. | $17.11 | 09/21/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 815628623 | CMS |
| Ocular Therapeutix, Inc. | $143.67 | 09/20/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 843882149 | CMS |
| Allergan, Inc. | $3,300.00 | 09/14/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863173 | CMS |
| Sight Sciences, Inc. | $14.81 | 09/10/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851129621 | CMS |
| Sight Sciences, Inc. | $126.13 | 09/09/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851129617 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.62 | 09/08/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367823 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $14.84 | 09/01/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164205 | CMS |
| Mallinckrodt Hospital Products Inc. | $122.33 | 08/31/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367821 | CMS |
| Sight Sciences, Inc. | $13.56 | 08/27/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851129615 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.29 | 08/25/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367819 | CMS |
| Allergan, Inc. | $4.76 | 08/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863167 | CMS |
| Allergan, Inc. | $2,750.00 | 08/24/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863169 | CMS |
| Allergan, Inc. | $129.95 | 08/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863171 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $39.20 | 08/23/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164193 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $4.00 | 08/23/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164195 | CMS |
| Ocular Therapeutix, Inc. | $14.71 | 08/23/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 843882159 | CMS |
| Allergan, Inc. | $50.00 | 08/12/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863149 | CMS |
| Allergan, Inc. | $3,850.00 | 08/12/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863151 | CMS |
| Allergan, Inc. | $88.00 | 08/12/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863153 | CMS |
| Allergan, Inc. | $89.81 | 08/12/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863155 | CMS |
| Allergan, Inc. | $209.43 | 08/12/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863157 | CMS |
| Allergan, Inc. | $532.59 | 08/12/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863159 | CMS |
| Allergan, Inc. | $440.00 | 08/12/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863161 | CMS |
| Allergan, Inc. | $2,200.00 | 08/12/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863163 | CMS |
| Allergan, Inc. | $16.61 | 08/12/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863165 | CMS |
| Allergan, Inc. | $23.66 | 08/11/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863141 | CMS |
| Allergan, Inc. | $13.85 | 08/11/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863143 | CMS |
| Allergan, Inc. | $3,300.00 | 08/11/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863145 | CMS |
| Allergan, Inc. | $124.74 | 08/11/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863147 | CMS |
| Mallinckrodt Hospital Products Inc. | $16.89 | 08/11/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367817 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $92.49 | 08/10/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164191 | CMS |
| Alcon Vision LLC | $77.57 | 08/06/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 797755515 | CMS |
| Allergan, Inc. | $2,750.00 | 08/04/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863137 | CMS |
| Allergan, Inc. | $93.54 | 08/04/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863139 | CMS |
| Kala Pharmaceuticals, Inc. | $17.50 | 07/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 815628613 | CMS |
| Kala Pharmaceuticals, Inc. | $18.42 | 07/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 815628619 | CMS |
| Allergan, Inc. | $1.37 | 07/29/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863135 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $11.49 | 07/28/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851164201 | CMS |
| Eyevance Pharmaceuticals LLC | $16.59 | 07/28/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 807289063 | CMS |
| Mallinckrodt Hospital Products Inc. | $13.64 | 07/28/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 845367815 | CMS |
| Allergan, Inc. | $4.00 | 07/27/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792863125 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $23,250.00 | 5 |
| PY2025 | Principal investigator | $79,116.12 | 21 |
| PY2024 | Recipient | $5,232.25 | 6 |
| PY2024 | Principal investigator | $103,432.68 | 13 |
| PY2023 | Principal investigator | $36,466.00 | 6 |
| PY2022 | Principal investigator | $36,539.21 | 8 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
26 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | ABBVIE INC. | $10,315.83 | 12/31/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1202534627 |
| Recipient | NEW WORLD MEDICAL,INC. | $10,625.00 | 12/16/2025 | Covered Recipient Physician | Streamline Retrospective Study | No dispute reported | 06/30/2026 | 1246943853 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $4,524.75 | 12/04/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209713 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 11/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209709 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $5,395.95 | 11/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209711 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 10/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209621 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 10/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209623 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 10/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209705 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $17,976.60 | 10/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209707 |
| Recipient | NEW WORLD MEDICAL,INC. | $5,250.00 | 09/16/2025 | Covered Recipient Physician | Streamline Retrospective Study | No dispute reported | 06/30/2026 | 1246943858 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $3,964.05 | 09/05/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209619 |
| Principal investigator 1 | Astellas Pharma Global Development | $7,793.00 | 08/22/2025 | Non-covered Recipient Entity Eye Associates of North Jersey PA | A Non-interventional, Observational Study to Evaluate Treatment Patterns and Safety of Avacincaptad Pegol (ACP/IZERVAY) in Routine Clinical Practice in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration | No dispute reported | 06/30/2026 | 1234182951 |
| Recipient | NEW WORLD MEDICAL,INC. | $875.00 | 08/08/2025 | Covered Recipient Physician | Streamline Retrospective Study | No dispute reported | 06/30/2026 | 1246943864 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $904.95 | 08/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209617 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 07/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209611 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $500.00 | 07/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209613 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $3,059.10 | 07/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209615 |
| Recipient | Ocular Therapeutix, Inc. | $2,500.00 | 06/30/2025 | Covered Recipient Physician | A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTX-TIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT) | No dispute reported | 06/30/2026 | 1250229250 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $750.00 | 06/06/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209609 |
| Recipient | NEW WORLD MEDICAL,INC. | $4,000.00 | 06/06/2025 | Covered Recipient Physician | Streamline Retrospective Study | No dispute reported | 06/30/2026 | 1246943870 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $1,017.30 | 05/09/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209607 |
| Principal investigator 1 | Dompe Farmaceutici S.p.A. | $3,228.59 | 04/09/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO) | No dispute reported | 06/30/2026 | 1248398298 |
| Principal investigator 1 | Dompe Farmaceutici S.p.A. | $750.00 | 04/04/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO) | No dispute reported | 06/30/2026 | 1248398296 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $4,440.00 | 03/04/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction | No dispute reported | 06/30/2026 | 1246979404 |
| Principal investigator 1 | BIOTISSUE HOLDINGS INC. | $6,750.00 | 02/07/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | TTAX03-CR010 | No dispute reported | 06/30/2026 | 1246209605 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $3,996.00 | 01/02/2025 | Non-covered Recipient Entity EYE ASSOCIATES OF NORTH JERSEY | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction | No dispute reported | 06/30/2026 | 1246979408 |